{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T17:06:56Z","timestamp":1780679216982,"version":"3.54.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T00:00:00Z","timestamp":1637107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Fundaci\u00f3n Merck Salud"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To identify consensus aspects related to the diagnosis, monitoring, and treatment of short stature in children to promote excellence in clinical practice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Delphi consensus organised in three rounds completed by 36 paediatric endocrinologists. The questionnaire consisted of 26 topics grouped into: (1) diagnosis; (2) monitoring of the small-for-gestational-age (SGA) patient; (3) growth hormone treatment; and (4) treatment adherence. For each topic, different questions or statements were proposed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After three rounds, consensus was reached on 16 of the 26 topics. The main agreements were: (1) diagnosis tests considered as a priority in Primary Care were complete blood count, biochemistry, thyroid profile, and coeliac disease screening. The genetic test with the greatest diagnostic value was karyotyping. The main criterion for initiating a diagnostic study was prediction of adult stature 2 standard deviations below the target height; (2) the main criterion for initiating treatment in SGA patients was the previous growth pattern and mean parental stature; (3) the main criterion for response to treatment was a significant increase in growth velocity and the most important parameter to monitor adverse events was carbohydrate metabolism; (4) the main attitude towards non-responding patients is to check their treatment adherence with recording devices. The most important criterion for choosing the delivery device was its technical characteristics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study shows the different degrees of consensus among paediatric endocrinologists in Spain concerning the diagnosis and treatment of short stature, which enables the identification of research areas to optimise the management of such patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s40618-021-01696-0","type":"journal-article","created":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T18:02:29Z","timestamp":1637172149000},"page":"887-897","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Delphi consensus on the diagnosis and treatment of patients with short stature in Spain: GROW-SENS study"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3344-8269","authenticated-orcid":false,"given":"R.","family":"Corripio-Collado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3740-4247","authenticated-orcid":false,"given":"C.","family":"Fern\u00e1ndez-Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7447-2914","authenticated-orcid":false,"given":"I.","family":"Gonz\u00e1lez-Casado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1240-0496","authenticated-orcid":false,"given":"F.","family":"Moreno-Maci\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9282-9139","authenticated-orcid":false,"given":"J.-P.","family":"L\u00f3pez-Siguero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2319-5096","authenticated-orcid":false,"given":"J.-I.","family":"Labarta-Aizp\u00fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,17]]},"reference":[{"issue":"1","key":"1696_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000502231","volume":"92","author":"PF Collett-Solberg","year":"2019","unstructured":"Collett-Solberg PF, Ambler G, Backeljauw PF, Bidlingmaier M, Biller BMK, Boguszewski MCS et al (2019) Diagnosis, genetics, and therapy of short stature in children: a growth hormone research society international perspective. Horm Res Paediatr 92(1):1\u201314. https:\/\/doi.org\/10.1159\/000502231","journal-title":"Horm Res Paediatr"},{"issue":"11","key":"1696_CR2","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1210\/jcem.85.11.6984","volume":"85","author":"Growth Hormone Research Society","year":"2000","unstructured":"Growth Hormone Research Society (2000) Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. GH Research Society. J Clin Endocrinol Metab 85(11):3990\u20133993. https:\/\/doi.org\/10.1210\/jcem.85.11.6984","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1696_CR3","first-page":"43","volume":"92","author":"C Barstow","year":"2015","unstructured":"Barstow C, Rerucha C (2015) Evaluation of short and tall stature in children. Am Fam Physician 92(1):43\u201350","journal-title":"Am Fam Physician"},{"issue":"5","key":"1696_CR4","first-page":"847","volume":"24","author":"V Mericq","year":"2013","unstructured":"Mericq V, Linares J, Riquelme J (2013) Talla baja: enfoque diagn\u00f3stico y bases terap\u00e9uticas. Rev Med Clin Condes 24(5):847\u2013856","journal-title":"Rev Med Clin Condes"},{"issue":"11","key":"1696_CR5","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1210\/jc.2008-0509","volume":"93","author":"P Cohen","year":"2008","unstructured":"Cohen P, Rogol AD, Deal CL, Saenger P, Reiter EO, Ross JL et al (2008) Consensus statement on the diagnosis and treatment of children with idiopathic short stature: a summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop. J Clin Endocrinol Metab 93(11):4210\u20134217. https:\/\/doi.org\/10.1210\/jc.2008-0509","journal-title":"J Clin Endocrinol Metab"},{"key":"1696_CR6","volume-title":"Instituto de Investigaci\u00f3n sobre Crecimiento y Desarrollo","author":"M Hern\u00e1ndez","year":"1988","unstructured":"Hern\u00e1ndez M, Castellet J, Narvaiza JL, Rinc\u00f3n JM, Ruiz I, S\u00e1nchez E et al (1988) Curvas y tablas de crecimiento. In: Hern\u00e1ndez Rodr\u00edguez M (ed) Instituto de Investigaci\u00f3n sobre Crecimiento y Desarrollo. Fundaci\u00f3n Faustino Orbegozo, Bilbao"},{"issue":"1","key":"1696_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-003735","volume":"4","author":"V Natale","year":"2014","unstructured":"Natale V, Rajagopalan A (2014) Worldwide variation in human growth and the World Health Organization growth standards: a systematic review. BMJ Open 4(1):e003735. https:\/\/doi.org\/10.1136\/bmjopen-2013-003735","journal-title":"BMJ Open"},{"key":"1696_CR8","unstructured":"World Health Organization Child growth standards. https:\/\/www.who.int\/toolkits\/child-growth-standards. Accessed 31 Mar 2021"},{"key":"1696_CR9","unstructured":"Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, L\u00e1zaro P, et al. The RAND\/UCLA Appropriateness Method User's Manual. http:\/\/www.rand.org\/pubs\/monograph_reports\/MR1269.html. Accessed 31 Mar 2021"},{"issue":"7001","key":"1696_CR10","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1136\/bmj.311.7001.376","volume":"311","author":"J Jones","year":"1995","unstructured":"Jones J, Hunter D (1995) Consensus methods for medical and health services research. BMJ 311(7001):376\u2013380. https:\/\/doi.org\/10.1136\/bmj.311.7001.376","journal-title":"BMJ"},{"issue":"11","key":"1696_CR11","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1515\/jpem.2005.18.11.1031","volume":"18","author":"FK Grote","year":"2005","unstructured":"Grote FK, Oostdijk W, de Muinck Keizer-Schrama SM, Dekker FW, Verkerk PH, Wit JM (2005) Growth monitoring and diagnostic work-up of short stature: an international inventorization. J Pediatr Endocrinol Metab 18(11):1031\u20131038. https:\/\/doi.org\/10.1515\/jpem.2005.18.11.1031","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"4","key":"1696_CR12","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1159\/000236082","volume":"72","author":"W Oostdijk","year":"2009","unstructured":"Oostdijk W, Grote FK, de Muinck Keizer-Schrama SM, Wit JM (2009) Diagnostic approach in children with short stature. Horm Res 72(4):206\u2013217. https:\/\/doi.org\/10.1159\/000236082","journal-title":"Horm Res"},{"issue":"5","key":"1696_CR13","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1159\/000444525","volume":"85","author":"MO Savage","year":"2016","unstructured":"Savage MO, Backeljauw PF, Calzada R, Cianfarani S, Dunkel L, Koledova E et al (2016) Early detection, referral, investigation, and diagnosis of children with growth disorders. Horm Res Paediatr 85(5):325\u2013332. https:\/\/doi.org\/10.1159\/000444525","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"1696_CR14","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jpeds.2013.04.002","volume":"163","author":"S Sisley","year":"2013","unstructured":"Sisley S, Trujillo MV, Khoury J, Backeljauw P (2013) Low incidence of pathology detection and high cost of screening in the evaluation of asymptomatic short children. J Pediatr 163(4):1045\u20131051. https:\/\/doi.org\/10.1016\/j.jpeds.2013.04.002","journal-title":"J Pediatr"},{"issue":"4","key":"1696_CR15","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1067\/mpd.2000.107390","volume":"137","author":"L Savendahl","year":"2000","unstructured":"Savendahl L, Davenport ML (2000) Delayed diagnoses of Turner\u2019s syndrome: proposed guidelines for change. J Pediatr 137(4):455\u2013459. https:\/\/doi.org\/10.1067\/mpd.2000.107390","journal-title":"J Pediatr"},{"issue":"3","key":"1696_CR16","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1136\/adc.2004.049817","volume":"90","author":"G Massa","year":"2005","unstructured":"Massa G, Verlinde F, De Schepper J, Thomas M, Bourguignon JP, Craen M et al (2005) Trends in age at diagnosis of Turner syndrome. Arch Dis Child 90(3):267\u2013268. https:\/\/doi.org\/10.1136\/adc.2004.049817","journal-title":"Arch Dis Child"},{"issue":"11","key":"1696_CR17","doi-asserted-by":"publisher","first-page":"E2125","DOI":"10.1210\/jc.2012-1739","volume":"97","author":"A Saari","year":"2012","unstructured":"Saari A, Sankilampi U, Hannila ML, Saha MT, Makitie O, Dunkel L (2012) Screening of turner syndrome with novel auxological criteria facilitates early diagnosis. J Clin Endocrinol Metab 97(11):E2125-2132. https:\/\/doi.org\/10.1210\/jc.2012-1739","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"1696_CR18","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1210\/jc.2006-0558","volume":"91","author":"K Stochholm","year":"2006","unstructured":"Stochholm K, Juul S, Juel K, Naeraa RW, Gravholt CH (2006) Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome. J Clin Endocrinol Metab 91(10):3897\u20133902. https:\/\/doi.org\/10.1210\/jc.2006-0558","journal-title":"J Clin Endocrinol Metab"},{"key":"1696_CR19","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2431-8-29","volume":"8","author":"L Duche","year":"2008","unstructured":"Duche L, Trivin C, Chemaitilly W, Souberbielle JC, Breart G, Brauner R et al (2008) Selecting short-statured children needing growth hormone testing: derivation and validation of a clinical decision rule. BMC Pediatr 8:29. https:\/\/doi.org\/10.1186\/1471-2431-8-29","journal-title":"BMC Pediatr"},{"issue":"3","key":"1696_CR20","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2015.25","volume":"169","author":"A Saari","year":"2015","unstructured":"Saari A, Harju S, Makitie O, Saha MT, Dunkel L, Sankilampi U (2015) Systematic growth monitoring for the early detection of celiac disease in children. JAMA Pediatr 169(3):e1525. https:\/\/doi.org\/10.1001\/jamapediatrics.2015.25","journal-title":"JAMA Pediatr"},{"key":"1696_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1471-2431-8-35","volume":"8","author":"P van Dommelen","year":"2008","unstructured":"van Dommelen P, Grote FK, Oostdijk W, Keizer-Schrama SM, Boersma B, Damen GM et al (2008) Screening rules for growth to detect celiac disease: a case-control simulation study. BMC Pediatr 8:35. https:\/\/doi.org\/10.1186\/1471-2431-8-35","journal-title":"BMC Pediatr"},{"issue":"2","key":"1696_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1046\/j.1365-2265.2002.01591.x","volume":"57","author":"S Cianfarani","year":"2002","unstructured":"Cianfarani S, Tondinelli T, Spadoni GL, Scire G, Boemi S, Boscherini B (2002) Height velocity and IGF-I assessment in the diagnosis of childhood onset GH insufficiency: do we still need a second GH stimulation test? Clin Endocrinol (Oxf) 57(2):161\u2013167. https:\/\/doi.org\/10.1046\/j.1365-2265.2002.01591.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"1696_CR23","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00431-014-2406-3","volume":"174","author":"Y Shen","year":"2015","unstructured":"Shen Y, Zhang J, Zhao Y, Yan Y, Liu Y, Cai J (2015) Diagnostic value of serum IGF-1 and IGFBP-3 in growth hormone deficiency: a systematic review with meta-analysis. Eur J Pediatr 174(4):419\u2013427. https:\/\/doi.org\/10.1007\/s00431-014-2406-3","journal-title":"Eur J Pediatr"},{"issue":"6","key":"1696_CR24","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/gim.2017.159","volume":"20","author":"NN Hauer","year":"2018","unstructured":"Hauer NN, Popp B, Schoeller E, Schuhmann S, Heath KE, Hisado-Oliva A et al (2018) Clinical relevance of systematic phenotyping and exome sequencing in patients with short stature. Genet Med 20(6):630\u2013638. https:\/\/doi.org\/10.1038\/gim.2017.159","journal-title":"Genet Med"},{"key":"1696_CR25","volume-title":"Estudio Transversal Espa\u00f1ol de Crecimiento 2008","author":"A Carrascosa","year":"2008","unstructured":"Carrascosa A, Fern\u00e1ndez JM, Ferr\u00e1ndez A, L\u00f3pez-Siguero JP, S\u00e1nchez E (2008) Estudio Transversal Espa\u00f1ol de Crecimiento 2008. Hercu, Barcelona"},{"issue":"6","key":"1696_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.anpedi.2010.03.017","volume":"73","author":"D L\u00f3pez de Lara","year":"2010","unstructured":"L\u00f3pez de Lara D, Santiago Paniagua P, Tapia Ruiz M, Rodr\u00edguez Mesa MD, Gracia Bouthelier R, Carrascosa LA (2010) Valoraci\u00f3n del peso, talla e IMC en ni\u00f1os, adolescentes y j\u00f3venes de la Comunidad Aut\u00f3noma de Madrid. An Pediatr (Barc) 73(6):305\u2013319","journal-title":"An Pediatr (Barc)"},{"key":"1696_CR27","unstructured":"Millennial's Growth. Estudio Longitudinal de Crecimiento Barcelona 1995\u20132017. http:\/\/www.millennialsgrowth.com\/. Accessed 31 Mar 2021"},{"issue":"3","key":"1696_CR28","doi-asserted-by":"publisher","first-page":"193.e191","DOI":"10.1016\/j.anpedi.2010.10.005","volume":"74","author":"E S\u00e1nchez Gonz\u00e1lez","year":"2011","unstructured":"S\u00e1nchez Gonz\u00e1lez E, Carrascosa Lezcano A, Fern\u00e1ndez Garc\u00eda JM, Fern\u00e1ndez Long\u00e1s A, L\u00f3pez de Lara D, L\u00f3pez-Siguero JP (2011) Estudios espa\u00f1oles de crecimiento: situaci\u00f3n actual, utilidad y recomendaciones de uso. An Pediatr (Barc) 74(3):193.e191-e116","journal-title":"An Pediatr (Barc)"},{"issue":"5","key":"1696_CR29","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000066265","volume":"58","author":"A Juul","year":"2002","unstructured":"Juul A, Bernasconi S, Clayton PE, Kiess W, DeMuinck-Keizer SS, Drugs S et al (2002) European audit of current practice in diagnosis and treatment of childhood growth hormone deficiency. Horm Res 58(5):233\u2013241. https:\/\/doi.org\/10.1159\/000066265","journal-title":"Horm Res"},{"issue":"3","key":"1696_CR30","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000503783","volume":"92","author":"G Binder","year":"2019","unstructured":"Binder G, Reinehr T, Ibanez L, Thiele S, Linglart A, Woelfle J et al (2019) GHD diagnostics in Europe and the US: an audit of national guidelines and practice. Horm Res Paediatr 92(3):150\u2013156. https:\/\/doi.org\/10.1159\/000503783","journal-title":"Horm Res Paediatr"},{"issue":"5","key":"1696_CR31","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/cen.13035","volume":"84","author":"AD Chesover","year":"2016","unstructured":"Chesover AD, Dattani MT (2016) Evaluation of growth hormone stimulation testing in children. Clin Endocrinol (Oxf) 84(5):708\u2013714. https:\/\/doi.org\/10.1111\/cen.13035","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"1696_CR32","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1159\/000452150","volume":"86","author":"A Grimberg","year":"2016","unstructured":"Grimberg A, DiVall SA, Polychronakos C, Allen DB, Cohen LE, Quintos JB et al (2016) Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency. Horm Res Paediatr 86(6):361\u2013397. https:\/\/doi.org\/10.1159\/000452150","journal-title":"Horm Res Paediatr"},{"issue":"1","key":"1696_CR33","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1136\/archdischild-2014-307228","volume":"101","author":"PG Murray","year":"2016","unstructured":"Murray PG, Dattani MT, Clayton PE (2016) Controversies in the diagnosis and management of growth hormone deficiency in childhood and adolescence. Arch Dis Child 101(1):96\u2013100. https:\/\/doi.org\/10.1136\/archdischild-2014-307228","journal-title":"Arch Dis Child"},{"issue":"3","key":"1696_CR34","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s40618-014-0201-7","volume":"38","author":"G Aimaretti","year":"2015","unstructured":"Aimaretti G, Attanasio R, Cannavo S, Nicoletti MC, Castello R, Di Somma C et al (2015) Growth hormone treatment of adolescents with growth hormone deficiency (GHD) during the transition period: results of a survey among adult and paediatric endocrinologists from Italy. Endorsed by SIEDP\/ISPED, AME, SIE, SIMA. J Endocrinol Invest 38(3):377\u2013382. https:\/\/doi.org\/10.1007\/s40618-014-0201-7","journal-title":"J Endocrinol Invest"},{"key":"1696_CR35","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ghir.2018.12.004","volume":"44","author":"PF Collett-Solberg","year":"2019","unstructured":"Collett-Solberg PF, Jorge AAL, Boguszewski MCS, Miller BS, Choong CSY, Cohen P et al (2019) Growth hormone therapy in children; research and practice\u2014a review. Growth Horm IGF Res 44:20\u201332. https:\/\/doi.org\/10.1016\/j.ghir.2018.12.004","journal-title":"Growth Horm IGF Res"},{"issue":"3","key":"1696_CR36","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1365-2265.2010.03833.x","volume":"73","author":"AJ Lem","year":"2010","unstructured":"Lem AJ, de Kort SW, de Ridder MA, Hokken-Koelega AC (2010) Should short children born small for gestational age with a distance to target height <1 standard deviation score be excluded from growth hormone treatment? Clin Endocrinol (Oxf) 73(3):355\u2013360. https:\/\/doi.org\/10.1111\/j.1365-2265.2010.03833.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"1696_CR37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nrendo.2016.138","volume":"13","author":"EL Wakeling","year":"2017","unstructured":"Wakeling EL, Brioude F, Lokulo-Sodipe O, O\u2019Connell SM, Salem J, Bliek J et al (2017) Diagnosis and management of Silver-Russell syndrome: first international consensus statement. Nat Rev Endocrinol 13(2):105\u2013124. https:\/\/doi.org\/10.1038\/nrendo.2016.138","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"1696_CR38","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1210\/jc.2006-2017","volume":"92","author":"PE Clayton","year":"2007","unstructured":"Clayton PE, Cianfarani S, Czernichow P, Johannsson G, Rapaport R, Rogol A (2007) Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. J Clin Endocrinol Metab 92(3):804\u2013810. https:\/\/doi.org\/10.1210\/jc.2006-2017","journal-title":"J Clin Endocrinol Metab"},{"key":"#cr-split#-1696_CR39.1","unstructured":"Ib\u00e1\u00f1ez Toda L, Grupo para el Estudio del Ni\u00f1o Peque\u00f1o para la Edad Gestacional de la Sociedad Espa\u00f1ola de Endocrinolog\u00eda Pedi\u00e1trica (2018) Peque\u00f1o para la edad gestacional: consecuencias endocrino-metab\u00f3licas. In: Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda de Atenci\u00f3n Primaria"},{"key":"#cr-split#-1696_CR39.2","unstructured":"(ed) Curso de actualizaci\u00f3n pediatr\u00eda 2018. L\u00faa Ediciones 3.0, Madrid, pp 179-190"},{"issue":"5","key":"1696_CR40","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1159\/000322878","volume":"75","author":"P Bang","year":"2011","unstructured":"Bang P, Bjerknes R, Dahlgren J, Dunkel L, Gustafsson J, Juul A et al (2011) A comparison of different definitions of growth response in short prepubertal children treated with growth hormone. Horm Res Paediatr 75(5):335\u2013345. https:\/\/doi.org\/10.1159\/000322878","journal-title":"Horm Res Paediatr"},{"issue":"2","key":"1696_CR41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2265.2012.04420.x","volume":"77","author":"P Bang","year":"2012","unstructured":"Bang P, Ahmed SF, Argente J, Backeljauw P, Bettendorf M, Bona G et al (2012) Identification and management of poor response to growth-promoting therapy in children with short stature. Clin Endocrinol (Oxf) 77(2):169\u2013181. https:\/\/doi.org\/10.1111\/j.1365-2265.2012.04420.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"1696_CR42","doi-asserted-by":"publisher","first-page":"E1072","DOI":"10.1210\/jc.2012-3888","volume":"98","author":"CL Deal","year":"2013","unstructured":"Deal CL, Tony M, Hoybye C, Allen DB, Tauber M, Christiansen JS et al (2013) Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab 98(6):E1072-1087. https:\/\/doi.org\/10.1210\/jc.2012-3888","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1696_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0016223","volume":"6","author":"WS Cutfield","year":"2011","unstructured":"Cutfield WS, Derraik JG, Gunn AJ, Reid K, Delany T, Robinson E et al (2011) Non-compliance with growth hormone treatment in children is common and impairs linear growth. PLoS ONE 6(1):e16223. https:\/\/doi.org\/10.1371\/journal.pone.0016223","journal-title":"PLoS ONE"},{"issue":"2","key":"1696_CR44","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s12020-020-02560-6","volume":"72","author":"MA de Arriba","year":"2021","unstructured":"de Arriba MA, Mu\u00f1iz VC, Saez JJA, Beisti A, Llovet E, Aizpun JIL (2021) Impact of adherence on growth response during the first 2 years of growth hormone treatment. Endocrine 72(2):513\u2013523. https:\/\/doi.org\/10.1007\/s12020-020-02560-6","journal-title":"Endocrine"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-021-01696-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-021-01696-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-021-01696-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T10:25:01Z","timestamp":1647080701000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-021-01696-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,17]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1696"],"URL":"https:\/\/doi.org\/10.1007\/s40618-021-01696-0","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,17]]},"assertion":[{"value":"23 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"RCC has no conflicts of interest to declare. She received funds as a consultant from Fundaci\u00f3n Merck Salud for this paper. CFR has no conflicts of interest to declare. She received funds as a consultant from Fundaci\u00f3n Merck Salud for this paper. IGC has no conflicts of interest to declare. She received funds as a consultant from Fundaci\u00f3n Merck Salud for this paper. FMM has no conflicts of interest to declare. She received funds as a consultant from Fundaci\u00f3n Merck Salud for this paper. JPLS has no conflicts of interest to declare. He received funds as a consultant from Fundaci\u00f3n Merck Salud for this paper. JILA has no conflicts of interest to declare. He received funds as a consultant from Fundaci\u00f3n Merck Salud for this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The panellists were invited to participate in the study by e-mail, informing them of the nature of the study through a presentation letter. Those who responded to the e-mail gave their consent to participate in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All authors of this work provided consent. The panel of participating experts were informed and gave their consent for publication of the results of the consensus.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}